The Immunologic Paradoxes of IgG4-Related Disease

Xiao Xiao, Min Lian, Weici Zhang, M. Eric Gershwin, Xiong Ma

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

IgG4-related disease (IgG4-RD), which usually occurs in middle-aged and elderly men, is a newly recognized fibroinflammatory condition characterized by swelling and sclerosis of involved organs, increased IgG4-positive plasma cell infiltration in lesions, and elevated IgG4 concentration in serum. Despite growing interest in the research, the pathophysiological mechanism remains elusive. Most IgG4-RD patients respond well to steroid therapy initially, but recurrent and refractory cases are common, especially in advanced fibrotic stage. Recent studies have documented the heterogeneity of the B cell lineages, which suggests their multiple functions in IgG4-RD beyond IgG4 production, such as cytokine secretion, antigen presentation, autoantibody production, and modulation of T and B cell interactions. Thus, a critical balance exists between pathogenic and regulatory B subsets to prevent immunopathology. A prompt response to B cell depletion therapy reported in recent cases strongly suggests the imbalance within B cell lineages in IgG4-RD. A more precise understanding of the pathogenesis of IgG4-RD will open up new perspectives for therapeutic strategy. With a particular emphasis on the novel B cell-targeted therapeutic strategies, this review highlights the immunologic features of IgG4-RD and the possible roles of B cell lineages in the pathogenesis of IgG4-RD.

Original languageEnglish (US)
Pages (from-to)1-8
Number of pages8
JournalClinical Reviews in Allergy and Immunology
DOIs
StateAccepted/In press - Feb 19 2018

Fingerprint

Immunoglobulin G
B-Lymphocytes
Cell Lineage
Antigen Presentation
Sclerosis
Cell- and Tissue-Based Therapy
Plasma Cells
Cell Communication
Autoantibodies
Therapeutics
Steroids
Cytokines
T-Lymphocytes
Serum
Research

Keywords

  • B cells
  • IgG4
  • IgG4-related disease
  • Plasmablasts
  • Rituximab

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

The Immunologic Paradoxes of IgG4-Related Disease. / Xiao, Xiao; Lian, Min; Zhang, Weici; Gershwin, M. Eric; Ma, Xiong.

In: Clinical Reviews in Allergy and Immunology, 19.02.2018, p. 1-8.

Research output: Contribution to journalArticle

@article{537aae55380742ce92bc303244ecdab9,
title = "The Immunologic Paradoxes of IgG4-Related Disease",
abstract = "IgG4-related disease (IgG4-RD), which usually occurs in middle-aged and elderly men, is a newly recognized fibroinflammatory condition characterized by swelling and sclerosis of involved organs, increased IgG4-positive plasma cell infiltration in lesions, and elevated IgG4 concentration in serum. Despite growing interest in the research, the pathophysiological mechanism remains elusive. Most IgG4-RD patients respond well to steroid therapy initially, but recurrent and refractory cases are common, especially in advanced fibrotic stage. Recent studies have documented the heterogeneity of the B cell lineages, which suggests their multiple functions in IgG4-RD beyond IgG4 production, such as cytokine secretion, antigen presentation, autoantibody production, and modulation of T and B cell interactions. Thus, a critical balance exists between pathogenic and regulatory B subsets to prevent immunopathology. A prompt response to B cell depletion therapy reported in recent cases strongly suggests the imbalance within B cell lineages in IgG4-RD. A more precise understanding of the pathogenesis of IgG4-RD will open up new perspectives for therapeutic strategy. With a particular emphasis on the novel B cell-targeted therapeutic strategies, this review highlights the immunologic features of IgG4-RD and the possible roles of B cell lineages in the pathogenesis of IgG4-RD.",
keywords = "B cells, IgG4, IgG4-related disease, Plasmablasts, Rituximab",
author = "Xiao Xiao and Min Lian and Weici Zhang and Gershwin, {M. Eric} and Xiong Ma",
year = "2018",
month = "2",
day = "19",
doi = "10.1007/s12016-018-8679-y",
language = "English (US)",
pages = "1--8",
journal = "Clinical Reviews in Allergy and Immunology",
issn = "1080-0549",
publisher = "Humana Press",

}

TY - JOUR

T1 - The Immunologic Paradoxes of IgG4-Related Disease

AU - Xiao, Xiao

AU - Lian, Min

AU - Zhang, Weici

AU - Gershwin, M. Eric

AU - Ma, Xiong

PY - 2018/2/19

Y1 - 2018/2/19

N2 - IgG4-related disease (IgG4-RD), which usually occurs in middle-aged and elderly men, is a newly recognized fibroinflammatory condition characterized by swelling and sclerosis of involved organs, increased IgG4-positive plasma cell infiltration in lesions, and elevated IgG4 concentration in serum. Despite growing interest in the research, the pathophysiological mechanism remains elusive. Most IgG4-RD patients respond well to steroid therapy initially, but recurrent and refractory cases are common, especially in advanced fibrotic stage. Recent studies have documented the heterogeneity of the B cell lineages, which suggests their multiple functions in IgG4-RD beyond IgG4 production, such as cytokine secretion, antigen presentation, autoantibody production, and modulation of T and B cell interactions. Thus, a critical balance exists between pathogenic and regulatory B subsets to prevent immunopathology. A prompt response to B cell depletion therapy reported in recent cases strongly suggests the imbalance within B cell lineages in IgG4-RD. A more precise understanding of the pathogenesis of IgG4-RD will open up new perspectives for therapeutic strategy. With a particular emphasis on the novel B cell-targeted therapeutic strategies, this review highlights the immunologic features of IgG4-RD and the possible roles of B cell lineages in the pathogenesis of IgG4-RD.

AB - IgG4-related disease (IgG4-RD), which usually occurs in middle-aged and elderly men, is a newly recognized fibroinflammatory condition characterized by swelling and sclerosis of involved organs, increased IgG4-positive plasma cell infiltration in lesions, and elevated IgG4 concentration in serum. Despite growing interest in the research, the pathophysiological mechanism remains elusive. Most IgG4-RD patients respond well to steroid therapy initially, but recurrent and refractory cases are common, especially in advanced fibrotic stage. Recent studies have documented the heterogeneity of the B cell lineages, which suggests their multiple functions in IgG4-RD beyond IgG4 production, such as cytokine secretion, antigen presentation, autoantibody production, and modulation of T and B cell interactions. Thus, a critical balance exists between pathogenic and regulatory B subsets to prevent immunopathology. A prompt response to B cell depletion therapy reported in recent cases strongly suggests the imbalance within B cell lineages in IgG4-RD. A more precise understanding of the pathogenesis of IgG4-RD will open up new perspectives for therapeutic strategy. With a particular emphasis on the novel B cell-targeted therapeutic strategies, this review highlights the immunologic features of IgG4-RD and the possible roles of B cell lineages in the pathogenesis of IgG4-RD.

KW - B cells

KW - IgG4

KW - IgG4-related disease

KW - Plasmablasts

KW - Rituximab

UR - http://www.scopus.com/inward/record.url?scp=85042189922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042189922&partnerID=8YFLogxK

U2 - 10.1007/s12016-018-8679-y

DO - 10.1007/s12016-018-8679-y

M3 - Article

C2 - 29460058

AN - SCOPUS:85042189922

SP - 1

EP - 8

JO - Clinical Reviews in Allergy and Immunology

JF - Clinical Reviews in Allergy and Immunology

SN - 1080-0549

ER -